No matter what stage a company or product is in during it's development lifecycle, informed decision-making is pivotal to the success of a new drug. Executive leaders at biotech and large pharma companies alike need to be aware of emerging trends in order to effectively focus their R&D and portfolio strategy, and ensure they navigate the competitive landscape to successfully guide a product from discovery through launch.

It takes a strong vision, the right teams, and a robust framework to map out the best plan for a company and effectively prioritize their research efforts and R&D spend to become leaders in today’s marketplace.